Menu

• Ask a Health Expert about STEM CELL TRANSPLANT
• Post Your Side Effect related to STEM CELL TRANSPLANT
• STEM CELL TRANSPLANT and FDA Warnings
• STEM CELL TRANSPLANT in Patients Wiki
• Report STEM CELL TRANSPLANT in Drug Side Effect Survey

STEM CELL TRANSPLANT side effect

What is STEM CELL TRANSPLANT ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Aldurazyme Side Effects Report #5600996-6
Physician from MEXICO reported ALDURAZYME problem on Jan 04, 2008. Male patient, child 5 years of age, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: stem cell transplant, . ALDURAZYME dosage: unknown. Patient died on 01/03/2008.

Avonex Side Effects Report #5510895-6
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 30, 2007. Male patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: stem cell transplant, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5500291-X
Health Professional from UNITED STATES reported ALDURAZYME problem on Oct 12, 2007. Female patient, child 2 years of age, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: stem cell transplant, . ALDURAZYME dosage: 17.4 MG QWK IV. Patient died.

Thalomid Side Effects Report #5322628-7
THALOMID problem was reported by a Health Professional from UNITED STATES on Apr 30, 2007. Male patient, 76 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: stem cell transplant, vascular bypass graft, . THALOMID dosage: 200 MG, DAILY, ORAL. Patient recovered.


Thalomid Side Effects Report #5305166-7
Physician from UNITED STATES reported THALOMID problem on Apr 06, 2007. Female patient, 70 years of age, was diagnosed with multiple myeloma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: stem cell transplant, . THALOMID dosage: 100-200MG, DAILY, ORAL. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5637182-X
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 15, 2008. Female patient, 35 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: complications of transplant surgery, stem cell transplant, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient died.

Exjade Side Effects Report #5500941-8
Consumer or non-health professional from UNITED STATES reported EXJADE problem on Oct 25, 2007. Male patient was diagnosed with acute myeloid leukaemia and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, stem cell transplant, . EXJADE dosage: 3000 MG, QD. Patient died.

Aldurazyme Side Effects Report #5442476-7
ALDURAZYME problem was reported by a Physician from UNITED STATES on Aug 17, 2007. Female patient, weighting 29.98 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: mucosal inflammation, stem cell transplant, . ALDURAZYME dosage: 0.58 MG/KG IV. Patient was hospitalized. Patient recovered.

Aldurazyme Side Effects Report #5390712-8
Physician from SPAIN reported ALDURAZYME problem on Apr 17, 2007. Female patient, child 5 years of age, weighting 30.86 lb, was diagnosed with mucopolysaccharidosis ih and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, stem cell transplant, . ALDURAZYME dosage: unknown. During the same period patient was treated with STEROIDS, ANTIBIOTICS, ANTIFUNGALS, DOPAMINE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL. Patient died on 10/18/2006.


Aldurazyme Side Effects Report #5390712-8
ALDURAZYME problem was reported by a Physician from SPAIN on Apr 17, 2007. Female patient, child 5 years of age, weighting 30.86 lb, was diagnosed with mucopolysaccharidosis ih and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: graft versus host disease, stem cell transplant, . ALDURAZYME dosage: unknown. During the same period patient was treated with STEROIDS, ANTIBIOTICS, ANTIFUNGALS, DOPAMINE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL. Patient died on 10/18/2006.

Cytarabine Side Effects Report #5776181-4
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on June 05, 2008. Female patient was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome, stem cell transplant, . CYTARABINE dosage: 100 MG/M2 DAILY. During the same period patient was treated with NEUPOGEN, MELPHALAN, ETOPOSIDE, DAUNORUBICIN, MITOXANTRONE. Patient died.

Velcade Side Effects Report #5741196-9
VELCADE problem was reported by a Health Professional from UNITED STATES on May 02, 2008. Male patient, 60 years of age, weighting 205.5 lb, was diagnosed with mantle cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: gastric ileus, stem cell transplant, . VELCADE dosage: 1.5 MG/M2, INTRAVENOUS. During the same period patient was treated with RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN. Patient was hospitalized. Patient recovered.

Rituxan Side Effects Report #5753593-6
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on May 27, 2008. Male patient, 59 years of age, weighting 200.0 lb, was diagnosed with hodgkin's disease and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: progressive multifocal leukoencephalopathy, stem cell transplant, . RITUXAN dosage: unknown. Patient died on 04/05/2007.

Busulfex Side Effects Report #5698172-4
BUSULFEX problem was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2008. Male patient, 49 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: sepsis, stem cell transplant, . BUSULFEX dosage: 32 ML, INTRAVENOUS. Patient was hospitalized. Patient recovered.


Vincristine Side Effects Report #5712880-8
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 30 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic analysis abnormal, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5712899-7
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 52 years of age, was diagnosed with b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5712908-5
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 54 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5712911-5
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 54 years of age, was diagnosed with b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5712940-1
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 56 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.


Vincristine Side Effects Report #5713409-0
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 48 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713410-7
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 44 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713414-4
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 56 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713419-3
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 52 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713494-6
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 25 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713496-X
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 38 years of age, was diagnosed with plasmacytoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE UNK. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713509-5
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 54 years of age, was diagnosed with b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE UNK. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713513-7
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 20 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE UNK. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713545-9
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 26 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713546-0
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 31 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713548-4
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 37 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713558-7
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 29 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713559-9
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 46 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713560-5
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 39 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713561-7
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 42 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713621-0
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 59 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE UNK. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713623-4
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 55 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713651-9
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713654-4
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 45 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713655-6
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 59 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713656-8
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 34 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713657-X
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 48 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713658-1
VINCRISTINE problem was reported by a Physician from GERMANY on Apr 08, 2008. Female patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Vincristine Side Effects Report #5713659-3
Physician from GERMANY reported VINCRISTINE problem on Apr 08, 2008. Female patient, 41 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, stem cell transplant, . VINCRISTINE dosage: 2 MG/M2 PER_CYCLE. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient recovered.

Doxorubicin Side Effects Report #5721261-2
DOXORUBICIN HYDROCHLORIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 20, 2007. Female patient, 49 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with DOXORUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: neutropenia, stem cell transplant, . DOXORUBICIN HYDROCHLORIDE dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, VINCRISTINE, CHLORAMBUCIL, CYCLOPHOSPHAMIDE, PREDNISONE, RITUXIMAB. Patient recovered.

Velcade Side Effects Report #5278947-6
Physician from FRANCE reported VELCADE problem on Mar 09, 2007. Female patient, 52 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: catheter site cellulitis, stem cell transplant, . VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, MELPHALAN. Patient was hospitalized. Patient recovered.

Fludara Side Effects Report #5282620-8
FLUDARA problem was reported by a Health Professional from UNITED KINGDOM on Mar 22, 2007. Female patient, 49 years of age, was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: autoimmune neutropenia, stem cell transplant, . FLUDARA dosage: 24 MG/M2, 6 CYCLES. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, CHLORAMBUCIL, DOXORUBICIN, PREDNISONE, VINCRISTINE. Patient recovered.

Clofarabine Side Effects Report #5673266-8
Physician from GERMANY reported CLOFARABINE problem on Jan 17, 2008. Female patient was diagnosed with acute leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: infection, multi-organ failure, stem cell transplant, venoocclusive disease, . CLOFARABINE dosage: 30 MG/M2, QDX5. During the same period patient was treated with CYTARABINE, CYCLOPHOSPHAMIDE, ANTITHYMOCYTE IMMUNOGLOBULIN, CYCLOSPORINE, MYCOPHENOLATE MOFETIL. Patient died.

Aldurazyme Side Effects Report #5600001-1
ALDURAZYME problem was reported by a Health Professional from UNITED STATES on Jan 03, 2008. Female patient, weighting 24.91 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: disease progression, mucopolysaccharidosis ih, stem cell transplant, . ALDURAZYME dosage: 5.8 MG, QW, INTRAVENOUS. During the same period patient was treated with BENADRYL, ACETAMINOPHEN. Patient died on 10/31/2007.

Busulfan Side Effects Report #5503595-X
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Oct 15, 2007. Male patient, 65 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, idiopathic pneumonia syndrome, stem cell transplant, . BUSULFAN dosage: 32 ML; QD; IV. During the same period patient was treated with FLUDARABINE PHOSPHATE, MELPHALAN, VALPROATE, NEUPOGEN, TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient died on 08/13/2007.

Velcade Side Effects Report #5448211-0
VELCADE problem was reported by a Physician from GERMANY on Aug 23, 2007. Female patient, 56 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: aplasia, pneumonia, stem cell transplant, . VELCADE dosage: unknown. During the same period patient was treated with MELPHALAN. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5465394-7
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Sept 12, 2007. Male patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: gastrointestinal tube insertion, multiple sclerosis, stem cell transplant, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.